Vanderbilt-Ingram website >
The patients exhibited lower heart rates, reported high satisfaction with virtual reality and experienced no feelings of cybersickness.
The study involved patients of diverse ethnic backgrounds age 66 or older who died from breast, prostate, pancreatic or lung cancers.
They have identified key research priority areas to deliver a fundamental understanding of appendiceal tumors and to improve treatments and outcomes for patients.
There, a multidisciplinary team offers cancer patients medical oncology, surgical oncology consultations, infusion services, palliative care and pain management.
The funds will support Justin Balko’s research on breast cancer and Kathleen DelGiorno’s research on pancreatic cancer.
During her tenure, Vanderbilt-Ingram experienced remarkable growth, including a 100% increase in research funding and a 160% expansion in inpatient visits.